ONE YEAR. ONE CGM.
Introducing Eversense 365. It’s the only one year CGM, and it’s designed to minimize device frustrations so you can manage your diabetes with one less burden in your way.
The Eversense 365 System
Eversense 365 is a long-term solution to the everyday frustrations of traditional, short-term CGMs.
A healthcare provider places the one year sensor under the skin of your upper arm.
The gentle silicone-based adhesive is replaced daily.
The sensor sends real-time glucose data to the smart transmitter.
The removable smart transmitter* sends glucose data to your app.
See how Eversense 365 works
Click the video below to see how the Eversense 365 CGM system monitors your glucose for a YEAR.
The Eversense 365 System.
Tiny One Year Sensor
KEY DETAILS
Only one sensor placement and warm-up period every year
The one year sensor stays comfortably in place without risk of falling out or being knocked off
Essentially no compression lows4
Removable* Smart Transmitter
KEY DETAILS
Real-time glucose readings every 5 minutes
Water-resistant in 1 meter of water for up to 30 minutes
Attaches to the body with gentle adhesive
No jabbing or irritated skin
Distinct on-body high and low vibe alerts
Gentle Adhesive
KEY DETAILS
Silicone-based
Changed daily, fresh and clean
Available in both clear and white color options
Mobile App & Alerts
KEY DETAILS
The only app with both high and low predictive alerts
Share real-time data from the Eversense app with your healthcare provider, plus all the friends and family you want with the Eversense Now app
View summary reports to better understand your glucose levels and trends
Who Qualifies for Eversense 365?
You could be a candidate for Eversense 365 if:
- You're an adult (18 or over) with diabetes
- You're taking insulin
- You have commercial insurance - Eversense 365 is covered by most commercial health plans6
- You are on Medicare - Eversense 365 is available to people with Medicare†
Pay as little as $199‡
Experience the Eversense 365 CGM system for as low as $199 for a full year. This includes the cost of both CGM sensor and transmitter.‡
One year CGM vs 10-14 days. You do the math.
Eversense 365 is a long-term solution to the everyday frustrations of traditional, short-term CGMs.
Pre-Qualify for Eversense 365
If you're on insulin, you might greatly benefit from Eversense 365. Whether you’re ready to get started now or just have additional questions about Eversense 365, an Ascensia Diabetes Care (Ascensia) representative can help.
You may pre-qualify for Eversense 365 based on your insurance type and diabetes therapy. Fill in and submit the form below and we’ll be in touch via phone or text. We’ll also send you information about Eversense 365 by email.
All fields marked with an asterisk (*) are required.
Thanks! We've got your info.
A Diabetes Therapy Associate will be in touch shortly, but if you want to reach out sooner, please call 1-945-221-9068.
To help expedite benefits verification, please have your doctor and insurance information handy.
We will attempt to reach you by phone first, and will send a text and email as well. The call may be displayed on your phone as "Eversense CGM". However, it will come from a number you are unfamiliar with, so be sure to check your voicemail box. The email from our representative will come from an @ascensia.com email address. If you haven’t received any email communications from our team within a few days, please check the spam folder in your email account.
You can also schedule your call with us at a date/time that is most convenient for you - just click here.
Looking forward to getting in touch with you!
Thanks! We've got your info.
Unfortunately, based on the insulin therapy regimen or insurance information you provided, you may not be eligible for Eversense E3 CGM. In order to qualify, you must be on multiple daily doses of insulin.
If your commercial insurance plan does not cover Eversense E3 CGM, our Eversense PASS™ program may help reduce your out-of-pocket cost for the product. .
If you have any questions, please reach out to 1-844-736-7348.
The Most Frequently Asked Questions
Eversense gives you real-time glucose readings through a small sensor that’s placed just under the skin of your upper arm by a healthcare provider. The smart transmitter sits above the sensor, sending glucose data to your app. Want to learn more about the science behind Eversense? Check out our “How Eversense Works” video!
The main difference between Eversense 365 and Eversense E3 is that Eversense 365 lasts for one year.
Eversense 365 is the only CGM that lasts for an entire year - see how we compare!
Download our discussion guide and bring it to your next appointment and talk to your doctor about how Eversense may be a better fit for your diabetes management plan. We will work with you and your healthcare provider to manage your insurance claim.
The tiny sensor is placed just under the skin of your upper arm by a trained healthcare provider. There's a small incision which is then closed with Steri-Strips (which you can remove within a few days) - no stitches involved. Then you're good to go for one year!
* There is no glucose data generated when the transmitter is removed
† Speak to an Eversense Expert for more information on Medicare coverage.
‡ Offer does not apply to the insertion and removal procedures. The Eversense PASS Program has limitations on eligibility. See website (bit.ly/EversensePass) for more details. Ascensia Diabetes Care reserves the right to change or terminate this program at any time without notice. The program benefit is capped per transaction. There may be instances in which patient out-of-pocket costs exceed what is detailed in the offer. Eversense E3 is not eligible for the PASS Program.
1. Abbott. (2024) Freestyle Libre 3 User Guide ART49385-001 Rev. A 04/24
2. Dexcom (2024) G7 User Guide AW00078-10 Rev 003 MT-00078-10
3. Senseonics. (2024) Eversense 365 Continuous Glucose Monitoring System User Guide. LBL-7702-01-001 Rev A
4. Christiansen MP et al. A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II. DIABETES TECHNOLOGY & THERAPEUTICS 2018; 20(3):197-206
5. Deiss, D. et al. (2020). Real-world safety of an implantable continuous glucose sensor over multiple cycles of use: A post-market registry study. Diabetes Technology and Therapeutics, 22(1), 48–52. https://doi.org/10.1089/dia.2019.0159
6. Data on File. Senseonics. Policy Reporter (8/23/2024)
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
PP-SENS-365-GBL-0018